"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
For the relief of moderate pain
DOSAGE AND ADMINISTRATION
Adults. The usual adult dose is 2 caplets three or four times a day.
Pediatric Patients. Since clinical experience in pediatric patients under 12 years of age is limited, administration of TALWIN Compound (pentazocine and aspirin) in this age group is not recommended.
Duration of Therapy. Patients with chronic pain who receive pentazocine orally for prolonged periods have only rarely been reported to experience withdrawal symptoms when administration was abruptly discontinued (see WARNINGS). Tolerance to the analgesic effect of pentazocine has also been reported only rarely. Significant abnormalities of liver and kidney function tests have not been reported, even after prolonged administration of pentazocine.
Caplets, white, each containing pentazocine hydrochloride equivalent to 12.5 mg base and aspirin 325 mg. Bottles of 100 (NDC 0024-1927-04).
Store at room temperature up to 30° C (86° F).
Last reviewed on RxList: 1/28/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Talwin Compound Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.